Depot-medroxy Progesterone Acetate Injectable Contraceptives in Lactating Women 1st Week Versus 6 Week Postpartum Initiation

Not Applicable

Completed

• Conditions: Complications of DMPA Injectable Contraceptives
• Interventions: Device: Depot-medroxy Progesterone Acetate Injectable Contraceptives

• Registration Number: NCT06100783
• Lead Sponsor: Assiut University

Brief Summary

This study aims to identify the effect of using Depot-medroxy progesterone acetate injectable contraceptives on lactating women mother and infant in 1st week versus 6th week postpartum initiation.

This study is open labeled -randomized clinical trial was used. It was conducted at woman's health hospital, Assuit University. This study applied on 120 lactating women, who divided into two equal group I (who used DMPA injectable in the 1st week postpartum) and group II (who used DMPA injectable in the 6th week postpartum). Each group included 60 lactating women). Follow up was carried out after 3 months from the first dose to determine the changes in the studied women's menstrual period, weight, breast feedings...etc.

Detailed Description

Not available

Study Timeline

• Study Start: 2021-01-01
• Primary Completion: 2022-08-01
• Status Verified: 2023-10
• Study Completion: 2023-10-01
• Study First Submitted: 2023-10-15
• Study First Submitted QC: 2023-10-20
• Last Update Submitted: 2023-10-20
• Study First Posted: 2023-10-25
• Last Update Posted: 2023-10-25

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 120

Inclusion Criteria

Desire contraception for at least one year Apparently healthy participant Age 20- 40 years old Term delivery Birth weight >2.5 kg multipara Intend to breastfeed at time of hospital discharge Those delivered normally or by caesarean section Ready to follow and need immediate contraception

Exclusion Criteria

Maternal health problems (DM, HTN, cardiac disease, anaemia, or any other obvious problem) Any maternal complications during labour Preterm delivery IUGR

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Women using DMPA after 6 weeks postpartum	Depot-medroxy Progesterone Acetate Injectable Contraceptives	-
Women using DMPA after 1 week postpartum	Depot-medroxy Progesterone Acetate Injectable Contraceptives	-

Primary Outcome Measures

Name	Time	Method
Pattern of vaginal bleeding postpartum	2021 to 2023	Number of bleeding days- number of pads per day

Secondary Outcome Measures

Name	Time	Method
Duration and frequency of breast milk	2021 to 2023	score of frequency of breast feeding

Trial Locations

Locations (1)

Boshra Hussien Ahmed; 🇪🇬 Assiut, Egypt